THe effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib

Journal of Bone and Mineral Metabolism

Volumn 23, Issue SUPPL. 1, 2005, Pages 36-42

  Mashiba, T ^a   Mori, S ^a   Komatsubara, S ^a   Cao, Y ^a   Manabe, T ^a   Norimatsu, H ^a   Burr, D B ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bisphosphonate; Cortical bone; Degree of mineralization; Microdamage; Remodeling

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ANIMAL; ARTICLE; BONE DENSITY; BONE MINERALIZATION; BONE REMODELING; DOG; DRUG EFFECT; FEMALE; INJURY; METABOLISM; PATHOLOGY; RIB;

ANIMALS; BONE DENSITY; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; DIPHOSPHONATES; DOGS; FEMALE; RIBS;

EID: 23844478623     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03026321     Document Type: Article

References (26)

1. DM Black SR Cummings DB Karpf JA Cauley DE Thompson MC Nevitt DC Bauer HK Genant WL Haskell R Marcus SM Ott JC Torner SA Quandt TF Reiss KE Ensrud 1996 Randomised trial of effect of alendronate on risk if fracture in women with existing vertebral fractures: Fracture Invention Trial research group Lancet 348 1535 1541
2. SR Cummings DM Black DE Thompson WB Applegate E Barrett-Connor TA Musliner L Palermo R Prineas SM Rubin JC Scott T Vogt R Wallace AJ Yates AZ Lacorix 1998 Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Invention Trial JAMA 280 2077 2082
3. J Reginster HW Minne OH Sorensen M Hooper C Roux ML Brandi B Lund D Ethgen S Pack I Roumagnac R Eastell 2000 Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group Osteoporos Int 11 83 91
4. KE Ensrud DM Black L Palermo DC Bauer E Barrett-Connor SA Quandt DE Thompson DB Karpf 1997 Treatment with alendronate prevents fractures in women at higher risk: results from the fracture intervention trial Arch Intern Med 157 2617 2624
5. H Fleisch 1997 Bisphosphonate: preclinical aspects and use in osteoporosis Ann Med 29 55 62
6. DB Karpf DR Shaprio E Seemann KE Ensrud CC Jr Jhonston S Adami ST Harris ACN Santona LJ Hirsch L Oppenheimer D Thompson 1997 Prevention of nonvertebral fractures by alendronate: a meta-analysis. Alendronate Osteoporosis Treatment Study Groups JAMA 277 1159 1164
7. ST,Watts NB Harris HK Genant CD McKeever T Hangartner M Keller CH III Chesnut J Brown EF Eriksen MS Hoseyni DW Axelrod PD Miller 1999 Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group JAMA 282 1344 1352
8. GY Boivin PM Chavassieux AC Santora J Yates PJ Meunier 2000 Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women Bone 27 687 694
9. PJ Meunier G Boivin 1997 Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications Bone 21 373 377
10. DB Burr MR Forwood DP Fyhrie RB Martin MB Shaffler CH Turner 1997 Bone microdamage and skeletal fragility in osteoporosis and stress fracture J Bone Miner Res 12 6 15
11. HM Frost 1998 A brief review for orthopedic surgeons: fatigue damage (microdamage) in bone (its determinants and clinical implications) J Orthop Sci 3 272 281
12. T Mashiba T Hirano CH Turner MR Forwood CC Johnston DB Burr 2000 Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biome-chanical properties in dog rib J Bone Miner Res 15 613 620
13. T Mashiba CH Turner T Hirano MR Forwood CC Johnston DB Burr 2001 Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles Bone 28 524 531
14. S Komatsubara S Mori T Mashiba M Ito Y Kaji T Akiyama K Miyamoto Y Cao J Kawanishi H Norimatsu 2002 Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra J Bone Miner Res 18 512 520
15. S Komatsubara S Mori T Mashiba J Li K Nonaka Y Kaji T Akiyama K Miyamoto Y Cao J Kawanishi H Norimatsu 2004 Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib J Bone Miner Res 19 999 1005
16. DB Burr BS Stafford 1990 Validity of bulk-staining technique to separate artificial from in vivo bone microdamage Clin Orthop 260 305 308
17. DB Burr M Hooser 1995 Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo Bone 17 431 433
18. AM Parfitt MK Drezner MK Glorieux FH Kanis JA Malluche PJ Meunier SM Ott RR Recker 1987 Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR histomorphometry nomenclature committee J Bone Miner Res 21 595 610
19. TE Wenzel MB Schaffler DP Fyhrie 1996 In vivo trabecular microcracks in human vertebral bone Bone 19 89 95
20. S Mori R Harruff W Ambrosius DB Burr 1997 Trabecular bone volume and microdamage accumulation in the femoral heads of women with and without femoral neck fractures Bone 21 521 526
21. Mori S, Li J, Kawaguchi Y (2001) The histological appearance of stress fracture. In: Burr DB, Milgrom C (eds) Musculoskeletal Fatigue and Stress Fractures. CRC Press, New York, pp 151-159
22. G Boivin PJ Meunier 2002 The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography Calcif Tissue Int 70 503 511
23. O Akkus F Adar MB Schaffler 2004 Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone Bone 34 443 153
24. MC Monier-Faugere Z Geng EP Paschalis Q Qi I Arnala F Bauss AL Boskey HH Malluche 1999 Intermittent and continuous administration of the bisphosphonate ibandronate in ovariectomized beagle dogs: effects on bone morphometry and mineral properties J Bone Miner Res 14 1768 1778
25. HG Bone D Hosking JP Devogelaer JR Tucci RD Emkey RP Tonino JA Rodriguez-Portales RW Downs J Gupta AC Santora UA Liberman Alendronate Phase III Osteoporosis Treatment Study Group 2004 Ten years' experience with alendronate for osteoporosis in postmenopausal women N Engl J Med 350 1189 1199
26. R Recker K Ensrud S Diem E Cheng S Bare P Masarachia P Roschger P Fratzl K Klaushofer A Lombardi D Kimmel 2004 Normal bone histomorphometry and 3D micrarchitecture after 10 years alendronate treatment of postmenopausal women J Bone Miner Res 19 S45 S45